PLSE

Pulse Biosciences Inc.

Price

$47.02

return (12m)

196.47%

p/e

-38.45

p/bv

30.94

DIVIDEND YIELD

0.00%

PLSE price

Pulse Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PLSE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

53.46%

3 months

83.96%

1 year

196.47%

2 years

135.57%

5 years

114.51%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals PLSE

Valuation

P/E

-38.45

Sector -2.19

Industry 1.21

P/BV

30.94

Sector 2.22

Industry 2.11

P/Revenue (PSR)

2,608.55

Sector 2.01

Industry 0.78

EV/EBITDA

-118.96

Sector -17.81

Industry -25.30

EV/EBIT

-117.79

Sector -26.72

Industry -18.04

P/EBITDA

-37.53

Sector 0.36

Industry 0.18

P/EBIT

-37.07

Sector -3.34

Industry 1.26

P/Total Assets

26.64

Sector 1.23

Industry 0.86

P/Net Current Assets

34.34

Sector -27.35

Industry -12.37

P/Working Capital

32.50

Sector -4.54

Industry -49.48

EPS

-1.16

Sector -0.87

Industry -0.55

BVPS

1.44

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

0.00%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-5,818.60%

Sector -323.65%

Industry -73.39%

EBIT Margin

-5,876.74%

Sector -194.57%

Industry -11.94%

Operating Margin

-100.00%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-100.00%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.00

Sector 0.12

Industry 0.22

Profitability

ROE

-80.46%

Sector -33.82%

Industry -37.56%

ROA

-69.28%

Sector -29.63%

Industry -17.56%

ROIC

-655.22%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

9.63

Sector 1.84

Industry 1.14

Net Debt / EBITDA

4.06

Sector -1.47

Industry -31.86

Net Debt / EBIT

4.02

Sector -1.32

Industry 2.06

Net Debt / Equity

-1.02

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.00

Sector 0.14

Industry 0.51

Equity/Assets

0.86

Sector 0.42

Industry 0.25

Liabilities/Assets

0.14

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

-3.50%

Sector -

Industry -

5Y Earnings CAGR

4.69%

Sector -

Industry -

Fundamentals PLSE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PLSE Pulse Biosciences Inc.	$47.02	199.87%	0.00%	-38.45	30.94	-80.46%	-100.00%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%
DXCM DexCom Inc.	$89.88	11.21%	0.00%	34.58	13.19	38.14%	20.12%
EW Edwards Lifesciences Corp.	$92.28	17.85%	0.00%	52.70	4.94	9.37%	15.43%
BDX Becton Dickinson and Company	$187.60	-0.85%	2.30%	53.25	2.05	3.85%	4.05%
IMRA Imara Inc.	$0.00	-100.00%	92.02%	65.05	1.13	1.74%	0.00%
BDXB Becton Dickinson and Company	$0.00	-100.00%	0.00%	8.75	0.54	6.12%	8.36%
ALGN Align Technology Inc.	$163.04	13.40%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.40	26.40%	1.45%	48.10	10.90	22.66%	26.71%
SNN Smith & Nephew PLC	$29.30	-16.53%	2.61%	11.16	2.43	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PLSE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Pulse Biosciences

Pulse Biosciences Inc.

Average Investor10 user rating

4.0 (0 people)

United States

12 years

Founded: 2014

2016

Time since IPO - 10 years

95

Employees

Pulse Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.08 billion, with shareholders equity totaling $99.50 million.

The company employs approximately 95 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Pulse Biosciences Inc. reported $1.18 million in revenue, generating net income of $-80.06 million.

Key financial metrics include a P/E ratio of -38.45, a price-to-book (P/B) ratio of 30.94, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PLSE.

Market cap

$3.08 billion

Net worth

$99.50 million

$99,500,000.00

Assets

$115.56 million

$115,560,000.00

Total Shares Outstanding

69.00 million

69,000,000

Average Daily Trading Volume

$387.39 Thousand

$387,388.00

Sector

Health

Industry

Medical Supplies and Equipment

PLSE

PLSE revenue and profits

Financial Results PLSE

DRAG THE FRAME TO SEE MORE DATA

PLSE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87